We are live on
!
Find out more
PFO
Pathstone Family Office Portfolio holdings
AUM
$13.1B
1-Year Est. Return
21.02%
This Fund
S&P 500
This Quarter
Est. Return
+0.72%
1 Year Est. Return
+21.02%
3 Year Est. Return
+39.27%
5 Year Est. Return
+59.47%
10 Year Est. Return
+236.85%
AUM
$768M
AUM Growth
-$80.1M
(-9.5%)
Cap. Flow
-$27.1M
Cap. Flow
% of AUM
-3.53%
Top 10 Holdings %
Top 10 Hldgs %
60.99%
Holding
740
New
85
Increased
91
Reduced
143
Closed
103
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$1.75M |
| 2 |
AMJ
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
|
+$1.16M |
| 3 |
Lyft
LYFT
|
+$989K |
| 4 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$721K |
| 5 |
Xylem
XYL
|
+$522K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royal Bank of Canada
RY
|
+$11.3M |
| 2 |
iShares Russell 1000 ETF
IWB
|
+$9.09M |
| 3 |
CarMax
KMX
|
+$5.75M |
| 4 |
iShares Core MSCI EAFE ETF
IEFA
|
+$2.77M |
| 5 |
Microsoft
MSFT
|
+$2.09M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 25.36% |
| 2 | Technology | 10.73% |
| 3 | Consumer Discretionary | 9.26% |
| 4 | Communication Services | 3.87% |
| 5 | Industrials | 3.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Aflac
AFL
$64.5B
| $763K | 0.1% |
14,574
| – | – |
|
|
77
Lyft
LYFT
$6.22B
| $750K | 0.1% |
18,350
+18,110
| +7,546% | +$989K |
|
78
Brown-Forman Class B
BF.B
$12.8B
| $746K | 0.1% |
11,882
-1,625
| -12% | -$95K |
|
79
iShares 7-10 Year Treasury Bond ETF
IEF
$47.1B
| $737K | 0.1% |
6,548
+5
| +0.1% | +$558 |
|
80
Visa
V
$683B
| $717K | 0.09% |
4,160
+1,051
| +34% | +$187K |
|
81
JPMorgan Chase
JPM
$937B
| $624K | 0.08% |
5,300
-12,644
| -70% | -$1.43M |
|
82
AT&T
T
$162B
| $602K | 0.08% |
21,028
-10,667
| -34% | -$283K |
|
83
KeyCorp
KEY
$24.5B
| $597K | 0.08% |
33,438
| – | – |
|
84
Home Depot
HD
$339B
| $588K | 0.08% |
2,538
-6,674
| -72% | -$1.46M |
|
85
Amplify BlueStar Israel Technology ETF
ITEQ
$115M
| $586K | 0.08% |
14,708
+3
| +0% | +$122 |
|
86
American Airlines Group
AAL
$10.6B
| $585K | 0.08% |
21,693
| – | – |
|
87
Credit Acceptance
CACC
$5.99B
| $561K | 0.07% |
1,215
+279
| +30% | +$132K |
|
88
Johnson & Johnson
JNJ
$613B
| $548K | 0.07% |
4,233
-6,893
| -62% | -$908K |
|
89
American Express
AXP
$233B
| $532K | 0.07% |
4,500
| – | – |
|
|
90
Xylem
XYL
$27.8B
| $529K | 0.07% |
+6,643
| New | +$522K |
|
91
Vanguard Russell 2000 ETF
VTWO
$17.6B
| $512K | 0.07% |
8,450
-278
| -3% | -$17.1K |
|
92
Comcast
CMCSA
$87.2B
| $484K | 0.06% |
10,737
-13,829
| -56% | -$613K |
|
93
iShares Russell 2000 Growth ETF
IWO
$14.6B
| $483K | 0.06% |
2,506
-208
| -8% | -$41.2K |
|
94
JD.com
JD
$44.6B
| $472K | 0.06% |
16,719
| – | – |
|
|
AGN
95
DELISTED
Allergan plc
AGN
| $467K | 0.06% |
2,774
| – | – |
|
96
McCormick & Company Non-Voting
MKC
$13.9B
| $461K | 0.06% |
5,902
+2
| +0% | +$161 |
|
97
CALL
iShares Core S&P 500 ETF
IVV
$884B
| $455K | 0.06% |
+152,400
| New | +$45.3M |
|
98
ExxonMobil
XOM
$643B
| $450K | 0.06% |
6,394
-12,790
| -67% | -$925K |
|
99
iShares Core S&P Mid-Cap ETF
IJH
$124B
| $440K | 0.06% |
11,365
-6,440
| -36% | -$247K |
|
100
Lam Research
LRCX
$369B
| $436K | 0.06% |
18,870
| – | – |
|
Similar funds
CG
API
TA
SCH
PWAG
CS
IWP
MAM
Pathstone Family Office's Q3 2019 Portfolio in Review
As of Q3 2019, Pathstone Family Office held 740 positions worth $768M, down 9.5% from $848M the previous quarter. Its ten largest holdings account for 61% of the portfolio.
Pathstone Family Office withdrew a net $27.1M in Q3 2019, closing 103 positions and reducing 143 holdings. Its most notable exit was UroGen Pharma, an estimated $1.47M position sold in full.
By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 25% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Pathstone Family Office opened a new position in Xylem worth $529K.
- Pathstone Family Office's largest Q3 2019 buy was Xylem: 6,643 shares worth $529K.
- Pathstone Family Office added most to Vanguard S&P 500 ETF in Q3 2019, an estimated $1.75M increase.
- Pathstone Family Office's biggest Q3 2019 reduction was Royal Bank of Canada, cutting an estimated $11.3M.
- Pathstone Family Office fully exited UroGen Pharma in Q3 2019, selling an estimated $1.47M.
- Pathstone Family Office's ten largest holdings make up 61% of its $768M portfolio in Q3 2019.
- Pathstone Family Office opened 85 new positions and closed 103 in Q3 2019.
- Pathstone Family Office's portfolio value fell 9.5% quarter-over-quarter to $768M.
Based on Pathstone Family Office's 13F filing for Q3 2019, filed 13 Nov 2019.